Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castration
Eur J Cancer
.
1990;26(6):770-1.
doi: 10.1016/0277-5379(90)90145-j.
Authors
A Dupont
,
H Boucher
,
L Cusan
,
Y Lacourciere
,
J Emond
,
F Labrie
PMID:
2144174
DOI:
10.1016/0277-5379(90)90145-j
No abstract available
Publication types
Letter
MeSH terms
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Bromocriptine / administration & dosage
Humans
Male
Octreotide / administration & dosage
Prostatic Neoplasms / drug therapy*
Substances
Bromocriptine
Octreotide